Off target effects of CRISPR/Cas9

Gene Editing Medical Application
1

Hi everyone

How can researchers minimize off-target effects in CRISPR-Cas9 gene editing to ensure precision and safety, especially in therapeutic applications? What are the latest advancements, such as high-fidelity Cas9 variants and computational prediction tools, that help improve targeting accuracy and reduce unintended mutations?

We are working on disrupting functional genes and are noticing oncogenic transformation. Is this because of non-specific/off Target binding?

Thanks

2

Harman You can see improvement in results using

  1. Use High-Fidelity Cas9 Variants

These are engineered versions of Cas9 with enhanced specificity:

  • SpCas9-HF1: Contains mutations that reduce non-specific interactions with DNA.
  • eSpCas9 (enhanced specificity): Designed to reduce off-target cleavage by minimizing non-specific binding.
  • HypaCas9: Modified in the REC3 domain to reduce unwanted interactions.

  1. Shorter sgRNA or Truncated gRNAs (tru-gRNAs)

  • Use 17-18 nt guide RNAs instead of full 20-nt guides.
  • Reduces tolerance for mismatches at off-target sites.
3 Likes